Cesca Therapeutics CEO Chris Xu's 2021 pay falls 63% to $748K
Cesca Therapeutics reports 2021 executive compensation
By ExecPay News
Published: November 1, 2022
Cesca Therapeutics reported fiscal year 2021 executive compensation information on November 1, 2022.
In 2021, two executives at Cesca Therapeutics received on average a compensation package of $549K, a 55% decrease compared to previous year.
Average pay of disclosed executives at Cesca Therapeutics
Chris Xu, Chief Executive Officer, received $748K in total, which decreased by 63% compared to 2020. 67% of Xu's compensation, or $500K, was in salary. Xu also received $248K in bonus.
Jeffery Cauble, Chief Financial Officer, received a compensation package of $349K, which decreased by 22% compared to previous year. 73% of the compensation package, or $254K, was in salary.
Related executives
You may also like
Source: SEC filing on November 1, 2022.